State Street Corporation 13D and 13G filings for BioCryst Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-17 11:52 am Sale |
2024-09-30 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
STATE STREET CORP STT |
8,849,588 4.300% |
-3,927,415 (-30.74%) |
Filing |
| 2024-01-24 1:06 pm Purchase |
2023-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
STATE STREET CORP STT |
12,777,003 6.240% |
1,650,142 (+14.83%) |
Filing |
| 2023-02-06 09:33 am Purchase |
2022-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
STATE STREET CORP STT |
11,126,861 5.970% |
2,877,832 (+34.89%) |
Filing |
| 2022-02-09 11:33 am Purchase |
2021-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
STATE STREET CORP STT |
8,249,029 4.580% |
940,213 (+12.86%) |
Filing |
| 2021-04-12 09:36 am Sale |
2021-03-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
STATE STREET CORP STT |
7,308,816 4.130% |
-3,748,163 (-33.90%) |
Filing |
| 2021-02-05 11:42 am Sale |
2020-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
STATE STREET CORP STT |
11,056,979 6.260% |
-6,896,891 (-38.41%) |
Filing |
| 2020-12-10 07:14 am Purchase |
2020-11-30 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
STATE STREET CORP STT |
17,953,870 10.170% |
17,953,870 (New Position) |
Filing |